ArticleAnnals of medicine and surgery (2012)2026
Machine learning algorithms and web-based prognostic tool for different histological subtypes of osteosarcoma: a retrospective cohort.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteosarcoma (OSC) is a rare but aggressive bone cancer and predicting survival outcomes remains a critical challenge in clinical practice. This study aims to evaluate the performance of machine learning models in predicting survival outcomes for OSC patients using regression and classification approaches. Methods: We analyzed data from 1471 OSC patients, with 55.7% male and a mean age of 26.13 years. Descriptive and survival analyses were performed using Python. Regression models (Linear Regression, LightGBM, XGBoost, and Random Forest) were deployed to predict survival as a continuous outcome and evaluated using mean absolute error (MAE), mean squared error (MSE), and Results: Among regression models, XGBoost performed best, achieving the lowest MAE (3.715) and MSE (20.788) and the highest Conclusion: Machine learning models, particularly XGBoost for regression and Logistic Regression for classification, demonstrate strong potential for predicting survival outcomes in OSC patients. These findings underscore the utility of machine learning in enhancing clinical decision-making and suggest avenues for future research, including incorporating additional clinical variables and advanced modeling techniques to improve long-term survival predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.